InvestSMART

Nyrada Inc (ASX: NYR) - Announcements

Current share price for NYR : $0.640 0.085 (15.32%)+

ASX company news and announcements for Nyrada Inc (NYR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Nyrada Inc (NYR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Nyrada Inc (NYR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Nyrada Inc (NYR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$158 Presentation - ASX SMIDCaps Conference 20 Mar 2026 8:37AM $0.505 $0.640 risen by 26.73%
$158 Nyrada PROTECT-MI Phase IIa Trial To Commence 19 Mar 2026 9:55AM $0.535 $0.640 risen by 19.63%
$158 Change of Director's Interest Notice - JM 9 Mar 2026 5:17PM $0.555 $0.640 risen by 15.32%
$158 Director Options Issue 20 Feb 2026 5:10PM $0.580 $0.640 risen by 10.34%
$158 Change of Director's Interest Notice - RW 20 Feb 2026 5:06PM $0.580 $0.640 risen by 10.34%
$158 Change of Director's Interest Notice - MF 20 Feb 2026 5:06PM $0.580 $0.640 risen by 10.34%
$158 Change of Director's Interest Notice - JM 20 Feb 2026 5:06PM $0.580 $0.640 risen by 10.34%
$158 Change of Director's Interest Notice - ID 20 Feb 2026 5:05PM $0.580 $0.640 risen by 10.34%
$158 Change of Director's Interest Notice - CC 20 Feb 2026 5:05PM $0.580 $0.640 risen by 10.34%
$158 Notification regarding unquoted securities - NYR 20 Feb 2026 4:49PM $0.580 $0.640 risen by 10.34%
$158 Capital Structure Update 18 Feb 2026 2:08PM $0.620 $0.640 risen by 3.23%
$158 Top 20 CDI Holder List 18 Feb 2026 2:05PM $0.620 $0.640 risen by 3.23%
$158 Nyrada Half Year FY2026 Results 18 Feb 2026 2:02PM $0.620 $0.640 risen by 3.23%
$158 Appendix 4D and Half Year Report to 31 December 2025 18 Feb 2026 1:58PM $0.650 $0.640 fallen by 1.54%
$158 Cleansing Statement 5 Feb 2026 5:17PM $0.820 $0.640 fallen by 21.95%
$158 Application for quotation of securities - NYR 5 Feb 2026 5:15PM $0.820 $0.640 fallen by 21.95%
$158 Investor Update Webinar 5 Feb 2026 8:21AM $0.920 $0.640 fallen by 30.43%
$158 Nyrada Phase IIa Clinical Trial Factsheet 5 Feb 2026 8:21AM $0.920 $0.640 fallen by 30.43%
$158 Change in substantial holding - Matt Corp WA PL 29 Jan 2026 4:57PM $0.840 $0.640 fallen by 23.81%
$158 Change in substantial holding - M Azzi 29 Jan 2026 4:51PM $0.840 $0.640 fallen by 23.81%
$158 Update to Nyrada Substantial Holders 29 Jan 2026 4:45PM $0.840 $0.640 fallen by 23.81%
$158 Nyrada Investor Webinar 28 Jan 2026 4:34PM $0.880 $0.640 fallen by 27.27%
$158 Cleansing Statement 23 Jan 2026 2:23PM $1.025 $0.640 fallen by 37.56%
$158 Application for quotation of securities - NYR 23 Jan 2026 2:22PM $1.025 $0.640 fallen by 37.56%
$158 Quarterly Activities Report and Appendix 4C 23 Jan 2026 8:52AM $0.935 $0.640 fallen by 31.55%

26 - 50 of 493 results

Page 2 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.